Equillium posts new preclinical EQ504 data in ulcerative colitis at AHR conference

Ahead of two poster presentations at the 7th International AHR Conference (Sep 29-Oct 2, 2026, Porto), Equillium disclosed new preclinical findings for EQ504 in ulcerative colitis, pointing to improved intestinal barrier repair and reduced inflammatory signaling.